This site is intended for healthcare professionals
FDA Hero Banner - Multi-coloured pills and tablets
FDA Drug information

PLERIXAFOR

Read time: 1 mins
Marketing start date: 03 May 2024
...
 

Summary of product characteristics


Effective Time

20230728

Version

1

Spl Product Data Elements

PLERIXAFOR plerixafor PLERIXAFOR PLERIXAFOR HYDROCHLORIC ACID SODIUM CHLORIDE SODIUM HYDROXIDE WATER

Application Number

ANDA208980

Brand Name

PLERIXAFOR

Generic Name

plerixafor

Product Ndc

70771-1776

Product Type

HUMAN PRESCRIPTION DRUG

Route

SUBCUTANEOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1776-1 Plerixafor Injection – 1.2 mL vial label 24 mg/1.2 mL (20 mg/mL) For subcutaneous injection only For single-dose only Rx only NDC 70771-1776-1 Carton contains one vial of Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) For subcutaneous injection only See package insert for dosage and administration For single-dose only Rx only vial label carton label

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.